Allspring Global Investments
NVS icon

Allspring Global Investments’s Novartis NVS Stock Holding History

Allspring Global Investments’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Sell
80,613
-21,982
-21% -$3.3M 0.02% 662
2026
Q1 		$15.9M Sell
102,595
-3,445
-3% -$528K 0.03% 582
2025
Q4 		$14.7M Buy
106,040
+339
+0.3% +$44.4K 0.02% 610
2025
Q3 		$13.9M Sell
105,701
-4,419
-4% -$539K 0.02% 619
2025
Q2 		$13.6M Sell
110,120
-2,349
-2% -$265K 0.02% 620
2025
Q1 		$12.3M Buy
112,469
+14,057
+14% +$1.5M 0.02% 654
2024
Q4 		$9.56M Buy
98,412
+55,581
+130% +$5.93M 0.02% 776
2024
Q3 		$4.93M Buy
42,831
+34,685
+426% +$3.94M 0.01% 947
2024
Q2 		$867K Buy
8,146
+3,392
+71% +$340K ﹤0.01% 1365
2024
Q1 		$460K Buy
4,754
+4,333
+1,029% +$444K ﹤0.01% 1550
2023
Q4 		$42.5K Sell
421
-85
-17% -$8.21K ﹤0.01% 1902
2023
Q3 		$51.5K Buy
506
+58
+13% +$5.89K ﹤0.01% 2263
2023
Q2 		$45.2K Buy
448
+27
+6% +$2.7K ﹤0.01% 2314
2023
Q1 		$38.7K Buy
421
+8
+2% +$699 ﹤0.01% 2362
2022
Q4 		$37.5K Sell
413
-12,160
-97% -$1.02M ﹤0.01% 2424
2022
Q3 		$955K Hold
12,573
– – ﹤0.01% 1434
2022
Q2 		$1.06M Sell
12,573
-4,418
-26% -$388K ﹤0.01% 1409
2022
Q1 		$1.49M Sell
16,991
-37,800
-69% -$3.27M ﹤0.01% 1660
2021
Q4 		$4.79M Buy
+54,791
New +$4.55M 0.01% 1188

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Allspring Global Investments's NVS Position: Q2 2026 in Review

Allspring Global Investments reduced its Novartis (NVS) stake by 21% in Q2 2026, selling an estimated $3.3M and leaving 80,613 shares worth $12.4M. The position accounts for 0.02% of the portfolio, ranked #662.

Allspring Global Investments first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $15.9M in Q1 2026. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Allspring Global Investments held 80,613 shares of Novartis worth $12.4M as of Q2 2026.
  • Allspring Global Investments sold 21,982 Novartis shares in Q2 2026, an estimated $3.3M.
  • Novartis made up 0.02% of Allspring Global Investments's portfolio in Q2 2026, its #662 holding.
  • Allspring Global Investments first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Novartis position peaked at $15.9M in Q1 2026.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.